Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study.
about
Role of Sirtuins in Linking Metabolic Syndrome with DepressionThe noradrenergic paradox: implications in the management of depression and anxietyThe role of cognitive dysfunction in the symptoms and remission from depressionInfluence of Pharmacotherapy on Cognitive Functions in Depression: A Review of the LiteratureBeyond Emotional and Spatial Processes: Cognitive Dysfunction in a Depressive Phenotype Produced by Long Photoperiod ExposureCognitive dysfunction and work productivity in major depressive disorder.The noradrenergic symptom cluster: clinical expression and neuropharmacology.Effect of agomelatine on memory deficits and hippocampal gene expression induced by chronic social defeat stress in miceCognitive and affective trait and state factors influencing the long-term symptom course in remitted depressed patients.Distinct Antidepressant-Like and Cognitive Effects of Antidepressants with Different Mechanisms of Action in Middle-Aged Female MiceAttitude and impact of perceived depression in the workplaceVortioxetine disinhibits pyramidal cell function and enhances synaptic plasticity in the rat hippocampus.Residual symptoms and functioning in depression, does the type of residual symptom matter? A post-hoc analysisCognitive dysfunction in major depressive disorder: effects on psychosocial functioning and implications for treatment.Depressive Symptoms Clusters and Insulin Resistance: Race/Ethnicity as a Moderator in 2005-2010 NHANES Data.Major depressive disorder as a nonlinear dynamic system: bimodality in the frequency distribution of depressive symptoms over timeNighttime heart rate predicts response to depression treatment in patients with coronary heart diseaseTrajectories of individual depressive symptoms in adolescents: gender and family relationships as predictors.Indoleamine 2,3-dioxygenase-dependent neurotoxic kynurenine metabolism mediates inflammation-induced deficit in recognition memoryChanges in energy during treatment of depression: an analysis of duloxetine in double-blind placebo-controlled trialsCognitive Deficits as a Mediator of Poor Occupational Function in Remitted Major Depressive Disorder Patients.Changes in cognitive versus somatic symptoms of depression and event-free survival following acute myocardial infarction in the Enhancing Recovery In Coronary Heart Disease (ENRICHD) study.A review of antidepressant therapy in primary care: current practices and future directions.Depressive symptom clusters as predictors of incident coronary artery disease: a 15-year prospective study.A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes.Treating to target in major depressive disorder: response to remission to functional recovery.Cognitive Remediation and Bias Modification Strategies in Mood and Anxiety Disorders.Are Non-steroidal Anti-Inflammatory Drugs Clinically Suitable for the Treatment of Symptoms in Depression-Associated Inflammation?Experimental Medicine in Psychiatry New Approaches in Schizophrenia, Depression and Cognition.The impact of cognitive challenges in major depression: the role of the primary care physician.A systematic review of cognitive effects of exercise in depression.Which Cognitive Domains are Improved by Treatment with Vortioxetine?Italian psychiatrists' perception on cognitive symptoms in major depressive disorder.Effectiveness of Supported Self-Help in Recurrent Depression: A Randomized Controlled Trial in Primary Care.The risk of new-onset diabetes in antidepressant users - A systematic review and meta-analysisCost per successfully treated patient for vortioxetine versus duloxetine in adults with major depressive disorder: an analysis of the complete symptoms of depression and functional outcome.Garcinia mangostana Linn displays antidepressant-like and pro-cognitive effects in a genetic animal model of depression: a bio-behavioral study in the Flinders Sensitive Line rat.Methylene blue and its analogues as antidepressant compounds.An ethnographic study of the effects of cognitive symptoms in patients with major depressive disorder: the IMPACT study.Functional impairment in patients with major depressive disorder: the 2-year PERFORM study.
P2860
Q26749937-1A7C93CD-147E-482E-9F48-E29400BD5F01Q26752868-02CB770D-C874-46C0-99B3-CDBC5659896EQ26781910-02598A12-87E3-4BAE-9E6F-0372B0529503Q27694555-A99E8ED2-C475-415E-825F-B24695358467Q29248013-0AD1B84C-4730-475F-B535-4A1BB16AE5C8Q30249792-2A6BB144-AC44-4CDD-A0FB-3C27D4D86095Q30474844-133AA0D1-B001-4253-9C9C-F0107D8BD7ABQ30843872-EDBFF797-4B66-47E0-8C82-12862D5D0988Q33757799-55A71327-7E52-4591-90D3-E822EB180A1DQ33762269-25E44DF8-1D0D-420D-B405-5F9E0369A6A2Q33833932-93F9ADF3-B303-48BF-8CB3-554F8F52E27DQ34505291-A749BDF1-0B96-4702-AEED-D0AF163B4738Q34582365-1797BA56-A95B-4E79-B360-B9BE5923CDABQ35006371-4AD75200-168B-478F-9C89-97ACC6ED22E7Q35759379-E50FDD27-B7F8-4569-85C2-D90A73B42ACCQ35780974-0E34D9FC-D9E3-4744-90DA-81A2AE2739BFQ36005301-002A83AA-27A3-4C27-AB3D-1EDDE9350E0FQ36112967-E05AD277-57E4-4EAC-8B0D-7B9AEE96C334Q36244916-E910DA4D-5314-448C-9D36-5A878971553AQ36380157-23DA9C7C-E3B9-4EC4-90B2-046B07F21A83Q36514336-D46A7756-E937-40D9-9D98-0C1907D7C6F2Q36901879-96920E4E-CA5D-4DCC-8EC2-D4868269A31DQ37070398-DFD6DB0F-CF40-4B99-AE37-553C61177C8DQ37477533-319028BD-FD36-40E3-A288-09966F7D8AA5Q38227967-3CEF28A1-963F-407F-9D41-57374D9B829AQ38673546-C0D508DA-FC37-46FE-BEDB-77B6995C0C69Q38787282-7768B32C-F23B-44ED-85B6-5AF5B8FD0422Q38894095-FC129D8B-97C6-4475-9625-A3EEDB5F526DQ38897362-61E944BF-721C-4954-A892-31E601AF0484Q38921636-20A4F3C5-ADD2-4FE2-B594-783EEE0B933EQ39097837-74CC0BC6-CCA4-4872-927E-B350855D0EFAQ39732375-C04DFBA3-AA83-4E78-A05A-69B62D3CA2C7Q40367558-C22D0AF8-228E-4709-9861-C902EB25B9D1Q40481118-B7F12786-0143-4878-8BFE-956816ED176DQ41185364-C59B5881-6F2F-4D82-8846-A8D7C62FDE15Q45937835-8269872E-0333-4444-BE33-8861BCC04EA4Q46199482-5D37FB69-59CF-4622-A310-A62FDFB69590Q46327960-CA57D938-1C3B-4F01-B39F-AC0EF2EFF80CQ47100418-E7794585-BBDB-4D9E-A711-C8DF6A150F74Q47640744-9D990080-F0DC-4B8F-A5E1-CF59650E5293
P2860
Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Presence of individual (residu ...... n: a 3-year prospective study.
@en
Presence of individual
@nl
type
label
Presence of individual (residu ...... n: a 3-year prospective study.
@en
Presence of individual
@nl
prefLabel
Presence of individual (residu ...... n: a 3-year prospective study.
@en
Presence of individual
@nl
P2093
P2860
P1476
Presence of individual (residu ...... n: a 3-year prospective study.
@en
P2093
P2860
P304
P356
10.1017/S0033291710001911
P407
P577
2010-10-08T00:00:00Z